SCHEMBL11277823

SCHEMBL11277823

CN1CCN2c3ccccc3C(=O)c3ccccc3C2C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 8/20 0.58
▸ HTR2C P28335 7/20 0.58
▸ HTR2B P41595 7/20 0.58
▸ DRD3 P35462 6/20 0.58
▸ HTR1A P08908 5/20 0.58
▸ DRD4 P21917 4/20 0.58
▸ LMNA P02545 3/20 0.58
▸ KMT2A Q03164 3/20 0.58
▸ HTR1D P28221 3/20 0.58
▸ MEN1 O00255 2/20 0.58
▸ TP53 P04637 2/20 0.58
▸ CYP3A4 P08684 2/20 0.58
▸ CYP1A2 P05177 2/20 0.58
▸ CYP2D6 P10635 2/20 0.58
▸ CYP2C9 P11712 2/20 0.58
▸ TSHR P16473 2/20 0.58
▸ CYP2C19 P33261 2/20 0.58
▸ CHRM2 P08172 2/20 0.58
▸ ADRA2A P08913 2/20 0.58
▸ CHRM1 P11229 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11289973 0.86 HTR2A (0.47) HTR2AHTR2CHTR2BDRD3HTR1A
SCHEMBL7409188 0.86 HTR2A (0.47) HTR2AHTR2CHTR2BDRD3HTR1A
SCHEMBL11377237 0.82 HTR2A (0.57) HTR2AHTR2CHTR2BDRD3HTR1A
SCHEMBL3633445 0.80 HTR2A (0.62) HTR2AHTR2CHTR2BDRD3HTR1A
SCHEMBL11364743 0.75 HTR2A (0.67) HTR2AHTR2CHTR2BDRD3HTR1A
SCHEMBL11364744 0.75 HTR2A (0.67) HTR2AHTR2CHTR2BDRD3HTR1A
SCHEMBL11288242 0.75 HTR2A (0.67) HTR2AHTR2CHTR2BDRD3HTR1A
SCHEMBL11364739 0.75 HTR2A (0.67) HTR2AHTR2CHTR2BDRD3HTR1A
Mianserin SCHEMBL23326358 0.74 DRD3 (1.00) HTR2AHTR2CHTR2BDRD3HTR1A
Mianserin SCHEMBL9122085 0.74 DRD3 (1.00) HTR2AHTR2CHTR2BDRD3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4333935-A Antianxiety compositions of 10-hydroxy 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino-1,2a azepines and a method of use thereof AKZONA INCORPORATED (US) 1982-06-08 — — US disclosed
US-4284559-A 10-Hydroxy-1,2,3,4,10,14b-hexahydrodibenzo-[c,f] pyrazino-1,2a-azepines AKZONA INCORPORATED (US) 1981-08-18 — — US disclosed
EP-0009284-A1 Novel tetracyclic compounds, processes for their preparation and pharmaceutical compositions AKZO N.V. (NL) 1980-04-02 — — EP disclosed
Send feedback